Eupraxia Pharmaceuticals Inc. financial data

Symbol
EPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 2067 Cadboro Bay Rd., Victoria, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
40-F - Q4 2023 - Apr 1, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.3M shares
Common Stock, Shares, Outstanding 27.3M shares +26.3%
Common Stock, Value, Issued 92.9M USD +30.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.3M USD +5.91%
Assets, Current 19.8M USD +6.53%
Property, Plant and Equipment, Net 410K USD -7.64%
Operating Lease, Right-of-Use Asset 46.7K USD -46.5%
Assets 20.3M USD +5.98%
Accounts Payable, Current 1.29M USD -28.8%
Liabilities, Current 19.4M USD +533%
Liabilities 19.4M USD +62.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.71M USD +2.86%
Retained Earnings (Accumulated Deficit) -106M USD -36.5%
Stockholders' Equity Attributable to Parent 2.22M USD -71.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 892K USD -87.6%
Liabilities and Equity 20.3M USD +5.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 27.3M shares +26.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.3M USD +5.91%
Deferred Tax Assets, Valuation Allowance 26.7M USD +55.5%
Operating Lease, Liability 53.3K USD -47.6%
Lessee, Operating Lease, Liability, to be Paid 60.8K USD
Property, Plant and Equipment, Gross 808K USD +9.69%
Operating Lease, Liability, Current 53.3K USD +5.78%
Lessee, Operating Lease, Liability, to be Paid, Year One 60.8K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.46K USD
Deferred Tax Assets, Operating Loss Carryforwards 18.3M USD +43.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD